Atropos Health

What Atropos Health does

Atropos Health is a healthcare technology company, incorporated in Delaware and headquartered in Palo Alto with offices in New York, that builds a clinical analytics platform for generating publication-grade Real-World Evidence (RWE) in minutes. The platform combines a generative AI layer with a proprietary Temporal Query Language (TQL), the GENEVA OS federated architecture, and the Atropos Evidence Network spanning 300M+ de-identified patient records across 100K+ conditions, medications, and 40+ clinical specialties. On top of this infrastructure the company ships Alexandria (a 33M+ pEBF evidence library targeting 2B by end of 2026), ChatRWD (a generative AI chat-to-study application), Green Button (a clinician-QC'd informatics consult service with a 48-hour SLA), the Atropos Evidence Agent, and Forge (a low-code research platform), validated by a 100% publication success rate in journals such as Cell, NEJM Catalyst, and JAMA.

The company serves two primary segments: Health Systems (academic medical centers and delivery networks using it for pharmacy/formulary, research informatics, value-based care, and graduate medical education) and Life Sciences (pharmaceutical, biotech, and life sciences organizations using it for HEOR, medical affairs, precision medicine AI/ML, R&D, and commercial analytics). It reports 7 of the top 10 global pharmaceutical companies as customers and named engagements with Stanford Health Care, Mayo Clinic, Emory, Prisma, Merck, Novartis, and Guidehouse.

Go-to-market blends enterprise direct sales with marketplace distribution (Google Cloud Marketplace, Databricks Marketplace) and OEM/embedded integrations into Microsoft Dragon Copilot, Microsoft Teams, Meta's clinical AI, and several workflow partners. Revenue is generated via quote-based subscription SaaS contracts on annual billing; specific pricing and revenue figures are not publicly disclosed. The company is venture-backed, having raised $14M in Series A (Aug 2022) and $33M in Series B (May 2024), with strategic investors including Valtruis, Cencora Ventures, McKesson Ventures, Merck Global Health Innovation Fund, and Breyer Capital.

Name

Atropos Health

Legal name

Atropos Health, Inc.

Website

https://www.atroposhealth.com/

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Atropos Health is a healthcare technology company that uses generative AI and a federated network of 300M+ patient records to generate publication-grade Real-World Evidence in minutes for health systems and life sciences organizations including 7 of the top 10 pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Real-World Evidence and Clinical Analytics Software

NAICS

Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industry

Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)

Keywords

• Real-world evidence platform
• Healthcare data analytics
• Clinical informatics consulting
• AI evidence generation
• Federated patient data

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Subscription-based SaaS: Cloud-based platform access with subscription pricing model. Provides on-demand data access, evidence generation tools, and analytics capabilities.

Pricing tiers

Go-to-market motion4 records

Distribution channels7 records

Marketing channels7 records

Core offering

Atropos Health provides a cloud-based AI platform that converts siloed healthcare data into publication-grade, personalized Real-World Evidence (RWE) in minutes. Its core stack combines the GENEVA OS operating system, the Atropos Evidence Network of 300M+ de-identified patient records, and the Alexandria evidence library, and it offers automation tools (ChatRWD, Green Button, Atropos Evidence Agent, Forge) and module suites for health systems and life sciences customers. Headquartered in Palo Alto and incorporated in Delaware, the company sells enterprise subscriptions to health systems, pharmaceutical companies, and clinical research teams, supported by SOC 2 Type II compliance and GXP-aligned data practices.

Product overview

Atropos Health is a healthcare technology company offering a platform-plus-modules architecture for generating high-quality personalized Real-World Evidence (RWE) in minutes and at scale. The core technology stack includes GENEVA OS (the foundational evidence generation operating system), the Atropos Evidence Network (a federated network of 300M+ patient records), and Alexandria (the world's largest medical evidence library with 33M+ pEBFs). Built on top of this infrastructure are automation solutions including ChatRWD (generative AI chat-to-database), Atropos Evidence Agent (expert RWE AI agent with MCP server), Green Button (clinical informatics consult service), and Forge (low-code research platform). The platform serves two main customer segments: Health Systems (Pharmacy, Research Informatics, Value Based Care, GME) and Life Sciences (Precision Medicine AI/ML, HEOR/Medical Affairs/RWE, R&D, Commercial Analytics). The company generates evidence 5-10x faster than traditional methods with a 48-hour SLA, 100% peer-reviewed publication success rate, and serves 7 of the top 10 pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Brands

• Alexandria®: The world's largest body of medical evidence library containing over 33 million precision Evidence-Based Findings (pEBFs), aimed at supporting clinical decision making and AI training.
• ChatRWD®
• Green Button®
• Forge®
• GENEVA OS®
• Atropos Evidence™ Agent

Products and services

• GENEVA OS Generative Evidence Acceleration Operating System — the foundational infrastructure platform that converts healthcare data into personalized evidence with federated multi-nodal queries, safe harbor encoding, and cross-node analytics without requiring data transfer; installs behind firewall.
• Alexandria Evidence Library The world's largest medical evidence library with 33M+ precision Evidence-Based Findings (pEBF), enabling clinicians, researchers, and life-science partners to generate precise answers to complex medical questions, validated through multi-layer AI, clinician, and third-party quality review.
• Atropos Evidence Agent Expert Real-World Evidence AI agent trained on Alexandria content that surfaces personalized evidence across pre-, during-, and post-visit clinical workflows; available as an MCP server on Databricks Marketplace and integrated with Microsoft Dragon Copilot and Teams.
• ChatRWD The first generative AI application to deliver full observational studies on healthcare data in minutes through a conversational interface, providing chat-to-database interaction, publication-grade Real-World Evidence, and refinement suggestions.
• Green Button Clinical informatics consult service delivering on-demand, clinician-QC'd publication-grade evidence in under 48 hours in formats such as Prognostograms, cohort counts, clinical phenotypes, and data visualizations.
• Forge Low-code research platform for technical and power users that supports cohort exploration, feasibility counts, eligibility-criteria iteration, and emulation of clinical-trial gaps in days, with control over charts, figures, and re-runnable queries.
• Atropos Evidence Network Largest federated data network in healthcare providing access to 300M+ de-identified patient records, 100K+ unique conditions and medications, and 40+ clinical specialties, with transactional purchasing and a 48-hour SLA on study questions.
• Data Quality Scoring (RWDS / RWFS) Data quality scoring solutions — Real World Data Score (RWDS) for dataset evaluation and Real World Fitness Score (RWFS) for fit-for-purpose assessment — designed to identify the most appropriate data for a given question via a quality scorecard.
• Health Systems Solutions Comprehensive solution suite for health systems spanning Pharmacy, Research Informatics, Value Based Care / Quality, and GME, delivering actionable clinical, financial, and operational evidence ROI.
• Life Sciences Solutions Solution suite for life-sciences teams covering Precision Medicine AI/ML, HEOR/Medical Affairs/RWE, Research & Development, and Commercial Analytics, providing 48-hour SLAs on RWE studies.

Quantifiable outcome

• 100% publication success rate in peer-reviewed journals
• +10 more outcomes

Named customers9 records

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration16 records

AI capability10 records

Feature11 records

Partnerships

Eleven partnerships are on record, tiered core.

• DatabrickscoreTechnology or Integration · 11 June 2026Expanded partnership bringing Atropos Evidence Agent MCP directly to Databricks Marketplace. Clinicians, researchers, and life sciences teams can now use AI agents to ask questions and get evidence-backed answers from real-world patient outcomes within their Databricks environment.
• GuidehousecoreStrategic or Co-development Partner · 18 May 2026Joint clinical decision support platform integrating real-world evidence into EHRs. Uses predictive analytics from aggregated claims and EHR data to support diagnosis, treatment decisions, and field engagement for life sciences organizations. Aims to bridge the 'Deployment Gap' with AI-driven insights at point of care.
• MetacoreTechnology or Integration · 22 April 2026Partnership to make Atropos medical library accessible through Meta's clinical AI technologies. Expands how healthcare providers access precision evidence within existing AI-driven workflows.
• MicrosoftcoreTechnology or Integration · 21 April 2026Microsoft Agent 365 integration through Azure AI agent infrastructure. Atropos Evidence Agent part of Wave 3 launch at HIMSS 2026 featuring enterprise governance tools for managing AI agents.
• ArcadiacoreTechnology or Integration · 21 April 2026Strategic partnership to bring Alexandria evidence into Arcadia's platform for value-based care analytics.
• Google CloudcoreTechnology or Integration · 6 November 2025Integration with Google Cloud Marketplace to provide greater access to real-world evidence for healthcare analytics, improving data accessibility and supporting healthcare research and decision-making.
• MicrosoftcoreTechnology or Integration · 20 October 2025Collaboration with Microsoft Dragon Copilot at Stanford Medicine to pilot AI-driven solution for personalized clinical evidence generation at point of care. Also integration with Microsoft Teams for multidisciplinary care team collaborations and ambient documentation interoperability.
• Stanford Health CarecoreStrategic or Co-development Partner · 20 October 2025Launch of Atropos Evidence Agent pilot at Stanford Medicine to improve evidence-based personalized medicine at point of care. Stanford physicians use the system for clinical decision support and research.
• NovartiscoreStrategic or Co-development Partner · 18 August 2025Partnership to develop AI models trained on real-world data for earlier identification and diagnosis of patients with paroxysmal nocturnal hemoglobinuria, a rare blood disorder that often goes undiagnosed for extended periods.
• MerckcoreStrategic or Co-development Partner · 13 January 2025Collaboration to accelerate evidence generation and analytics using Atropos AI-driven tools. Enables rapid cohort creation and publication-grade studies in less than 48 hours leveraging Atropos federated network of 300M+ patient records.
• Mayo Clinic PlatformcoreStrategic or Co-development Partner · 1 June 2022Partnership announced June 2022 to unlock insights from Mayo Clinic data using Atropos clinical informatics technology to accelerate better care.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Truveta: Provider of a large-scale de-identified health data platform and RWE analytics. Direct competitor in combining massive EHR-scale datasets with AI-driven evidence generation for pharma and health system customers.
• Flatiron Health: Oncology-focused real-world evidence and EHR data platform used by major pharma for research and clinical decision support. Closely comparable in the RWE-for-pharma and AMCs use cases Atropos targets.
• Komodo Health: Healthcare analytics platform built on 330M+ de-identified patient records used for patient journey, market sizing, and RWE. Directly comparable as software-first RWE platform for life sciences commercial and HEOR use cases.
• TriNetX: Federated health research network enabling cohort discovery, trial feasibility, and real-world studies across hundreds of healthcare organizations. Direct peer in trial emulation, protocol design, and clinical informatics consults.
• ConcertAI: AI and real-world evidence solutions company serving top pharma with oncology-focused analytics and clinical research tools. Overlapping customer base and HEOR / R&D use cases.

Broad incumbents

• Tempus AI: Public AI-powered precision medicine company with multimodal data library spanning clinical and molecular records for pharma R&D. Serves overlapping HEOR, R&D, and clinical decision customers at greater scale, with broader genomics and sequencing capabilities.
• IQVIA Real World Evidence: Global RWE and HEOR services leader tied to clinical research and lifecycle pharma evidence. Competes with Atropos for pharma HEOR, medical affairs, and commercial analytics budgets, but with heavy services-led delivery.
• Veradigm (Allscripts) Life Sciences: EHR-linked RWE and life sciences data provider offering longitudinal patient data and research solutions to pharma. Broader incumbent overlapping Atropos' health-system and pharma RWE businesses.

Others

• Databricks: Data + AI platform that distributes Atropos' MCP server on Databricks Marketplace and increasingly builds adjacent healthcare data capabilities. An ecosystem partner and indirect competitor via native RWE tooling on health data.
• Microsoft Dragon Copilot / Azure Health AI: Microsoft's clinical AI assistant and Azure AI infrastructure where Atropos Evidence Agent is embedded. Functions as a key OEM channel but also a broader incumbent capable of building or buying competing evidence generation capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/atroposhealth
• LinkedInlinkedin.com/company/atropos-health

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds4 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atropos Health